0001387131-18-007088.txt : 20181228 0001387131-18-007088.hdr.sgml : 20181228 20181228121204 ACCESSION NUMBER: 0001387131-18-007088 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20181228 DATE AS OF CHANGE: 20181228 GROUP MEMBERS: ALTIUM CAPITAL GROWTH GP, LLC GROUP MEMBERS: ALTIUM GROWTH GP, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Immutep Limited/ADR CENTRAL INDEX KEY: 0001692528 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-90754 FILM NUMBER: 181256674 BUSINESS ADDRESS: STREET 1: 120 BROADWAY STREET 2: 32ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10271 BUSINESS PHONE: 2122383128 MAIL ADDRESS: STREET 1: 120 BROADWAY STREET 2: 32ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10271 FORMER COMPANY: FORMER CONFORMED NAME: Prima Biomed Ltd/ADR DATE OF NAME CHANGE: 20161215 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Altium Capital Management LP CENTRAL INDEX KEY: 0001746382 IRS NUMBER: 822066653 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 551 FIFTH AVE - FL 19 CITY: NEW YORK STATE: NY ZIP: 10176 BUSINESS PHONE: 2124842711 MAIL ADDRESS: STREET 1: 551 FIFTH AVE - FL 19 CITY: NEW YORK STATE: NY ZIP: 10176 SC 13G 1 imm-sc13g_121918.htm ACQUISITION OF BENEFICIAL OWNERSHIP
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.)*

 
Immutep Limited

(Name of Issuer)

 

 
 
Sponsored ADR

(Title of Class of Securities)

 

 
 
45257L 10 8**

(CUSIP Number)

 

 
 
December 19, 2018
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

  Rule 13d-1(b)
     
  Rule 13d-1(c)
     
  Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

** The CUSIP number is for the American Depository Shares that trade on the NASDAQ Global Market, each representing 100 ordinary shares. No CUSIP number has been assigned to the ordinary shares.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 
CUSIP No . 45257L 10 8   Page 2 of 7

 

1

NAME OF REPORTING PERSON
Altium Capital Management, LP

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
(ENTITIES ONLY) EIN: 82-2066653

 
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)

(b)

3 SEC USE ONLY  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware, United States of America

 

NUMBER OF
SHARES

BENEFICIALLY
OWNED BY

EACH
REPORTING

PERSON
WITH:

5

SOLE VOTING

0

 
6

SHARED VOTING POWER

250,000,000*

200,000,000 issuable upon exercise of Warrants (see Item 4) **

 
7

SOLE DISPOSITIVE POWER

0

 
8

SHARED DISPOSITIVE POWER

250,000,000*

200,000,000 issuable upon exercise of Warrants (see Item 4) **

 
9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

250,000,000*

200,000,000 issuable upon exercise of Warrants (see Item 4) **

 
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

9.99% (see item 4) **

 
12

TYPE OF REPORTING PERSON

ia, OO

 
         

*The Reporting Person is deemed to beneficially own 250,000,000 Ordinary Shares based on beneficial ownership of 2,500,000 American Depository Shares, each representing 100 Ordinary Shares.

 

** The Reporting Person is deemed to beneficially own 200,000,000 Ordinary Warrants based on beneficial ownership of 2,000,000 American Depository Shares, each representing 100 Ordinary Warrants. As more fully explained in Item 4, the Ordinary Warrants are subject to a 9.9% blocker, and the percentage set forth in line (11) gives effect to such blockers. However, as more fully explained in Item 4, the securities reported in lines (6), (8), and (9) show the number of Ordinary Shares that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of Ordinary Shares beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities in lines (6), (8), and (9).

 

 

 

 
 
CUSIP No . 45257L 10 8   Page 3 of 7

 

1

NAME OF REPORTING PERSON
Altium Growth GP, LLC

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
(ENTITIES ONLY) EIN: 82-2105101

 
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)

(b)

3 SEC USE ONLY  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware, United States of America

 

NUMBER OF
SHARES

BENEFICIALLY
OWNED BY

EACH
REPORTING

PERSON
WITH:

5

SOLE VOTING

0

 
6

SHARED VOTING POWER

250,000,000*

200,000,000 issuable upon exercise of Warrants (see Item 4) **

 
7

SOLE DISPOSITIVE POWER

0

 
8

SHARED DISPOSITIVE POWER

250,000,000*

200,000,000 issuable upon exercise of Warrants (see Item 4) **

 
9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

250,000,000*

200,000,000 issuable upon exercise of Warrants (see Item 4) **

 
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

9.99% (see Item 4) **

 
12

TYPE OF REPORTING PERSON

PN

 
         

*The Reporting Person is deemed to beneficially own 250,000,000 Ordinary Shares based on beneficial ownership of 2,500,000 American Depository Shares, each representing 100 Ordinary Shares.

 

** The Reporting Person is deemed to beneficially own 200,000,000 Ordinary Warrants based on beneficial ownership of 2,000,000 American Depository Shares, each representing 100 Ordinary Warrants. As more fully explained in Item 4, the Ordinary Warrants are subject to a 9.9% blocker, and the percentage set forth in line (11) gives effect to such blockers. However, as more fully explained in Item 4, the securities reported in lines (6), (8), and (9) show the number of Ordinary Shares that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of Ordinary Shares beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities in lines (6), (8), and (9).

 

 

 

 
 
CUSIP No . 45257L 10 8   Page 4 of 7

 

1

NAME OF REPORTING PERSON

Altium Capital Growth GP, LLC

 

I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
(ENTITIES ONLY) EIN: 82-2086430

 
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)

(b)

3 SEC USE ONLY  
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware, United States of America

 

NUMBER OF
SHARES

BENEFICIALLY
OWNED BY

EACH
REPORTING

PERSON
WITH:

5

SOLE VOTING

0

 
6

SHARED VOTING POWER

250,000,000*

200,000,000 issuable upon exercise of Warrants (see Item 4) **

 
7

SOLE DISPOSITIVE POWER

0

 
8

SHARED DISPOSITIVE POWER

250,000,000*

200,000,000 issuable upon exercise of Warrants (see Item 4) **

 
9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

250,000,000*

200,000,000 issuable upon exercise of Warrants (see Item 4) **

 
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

9.99% (see Item 4) **

 
12

TYPE OF REPORTING PERSON

PN

 

 


*The Reporting Person is deemed to beneficially own 250,000,000 Ordinary Shares based on beneficial ownership of 2,500,000 American Depository Shares, each representing 100 Ordinary Shares.

 

** The Reporting Person is deemed to beneficially own 200,000,000 Ordinary Warrants based on beneficial ownership of 2,000,000 American Depository Shares, each representing 100 Ordinary Warrants. As more fully explained in Item 4, the Ordinary Warrants are subject to a 9.9% blocker, and the percentage set forth in line (11) gives effect to such blockers. However, as more fully explained in Item 4, the securities reported in lines (6), (8), and (9) show the number of Ordinary Shares that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of Ordinary Shares beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities in lines (6), (8), and (9).

 

 
 
CUSIP No. 45257L 10 8   Page 5 of 7

 

Item 1(a).   Name of Issuer: Immutep Limited (the “Issuer”)
     
Item 1(b).   Address of Issuer’s Principal Executive Offices:  

Level 12, 95 Pitt Street

Sydney, 2000 New South Wales, Australia

     
Item 2(a).  

Name of Person Filing:

This statement is jointly filed by and on behalf of each of Altium Growth Fund, LP, Altium Capital Management, LLC, and Altium Growth GP, LLC. Altium Growth Fund, LP is the record and direct beneficial owner of the securities covered by this statement. Altium Capital Management, LP is the investment adviser of, and may be deemed to beneficially own securities, owned by, Altium Growth Fund, LP. Altium Growth GP, LLC is the general partner of, and may be deemed to beneficially own securities owned by, Altium Growth Fund, LP.

 

Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.

 

Each of the reporting person may be deemed to be a member of a group with respect to the Issuer or securities of the Issuer for the purposes of Section 13(d) or 13(g) of the Act. Each of the reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

     
     
Item 2(b).   Address of Principal Business Office or, if None, Residence:
    The address of the principal business office of each of the reporting person is 551FifthAve, FL 19 New York, NY 10176
     
Item 2(c).   Citizenship:
    See Item 4 on the cover page(s) hereto.
     
     
Item 2(d).   Title of Class of Securities:
    Sponsored ADR
     
     
Item 2(e).   CUSIP Number: 45257L 10 8
     
     
     
Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a:
   
  (a) Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
       
  (b) Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
       
  (c) Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
       
  (d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
  (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
         
 
 
CUSIP No . 45257L 10 8   Page 6 of 7

 

  (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
  (g) A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G);
       
  (h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
       
  (j) Group, in accordance with §240.13d-1(b)(1)(ii)(J).
       
Item 4. Ownership.
   
  Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
       
       

The information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is set forth in lines 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in line 11 of the cover page for each Reporting Person is based on 3,344,431,269 Ordinary Shares issued and outstanding as of December 18, 2018, as represented in the Company’s Prospectus Supplement on Form 424(b)(5) filed with the Securities and Exchange Commission on December 18, 2018, and assumes the exercise of the Company's reported Ordinary Warrants (the "Reported Warrants"), subject to the Blockers (as defined below).

 

Pursuant to the terms of the Reported Warrants, the Reporting Person cannot exercise the Reported Warrants to the extent the Reporting Person would beneficially own, after any such exercise, more than 9.99% of the outstanding Ordinary Shares (the "Warrant Blockers"), and the percentage set forth in line 11 of the cover page for each Reporting Person gives effect to the Blockers. 

 

 

 
 
CUSIP No . 45257L 10 8   Page 7 of 7

 

Item 5. Ownership of Five Percent or Less of a Class.
   
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following 
   
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
  Not applicable
   
   
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
  Not applicable
   
   
Item 8. Identification and Classification of Members of the Group.
  Not applicable
   
   
Item 9. Notice of Dissolution of Group.
  Not applicable
   
   
Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

  Dated: December 28, 2018
   
  Altium Capital Management, LP
   
  By: /s/ Jacob Gottlieb
  Name: Jacob Gottlieb
  Title: CEO
     
  Altium Capital Growth GP, LLC
     
  By: Altium Growth GP, LLC
  Its: General Partner
     
  Signature: /s/  Jacob Gottlieb
  Name: Jacob Gottlieb
  Title: CEO
     
     
 

Altium Growth GP, LLC

   
  By: /s/  Jacob Gottlieb
  Name: Jacob Gottlieb
  Title: CEO